Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Resistant to Drugs”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Not applicableUnknownNCT03827811
What this trial is testing

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
University of Cape Town 625
Testing effectiveness (Phase 2)Study completedNCT02257918
What this trial is testing

Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

Who this might be right for
Gonorrhoea
National Institute of Allergy and Infectious Diseases (NIAID) 180
Not applicableStudy completedNCT02816931
What this trial is testing

Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations

Who this might be right for
Tuberculosis, Multidrug Resistant
Karolinska Institutet 37
Not applicableStudy completedNCT02791386
What this trial is testing

Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy

Who this might be right for
Hepatitis B
Bristol-Myers Squibb 383
Not applicableStudy completedNCT05667207
What this trial is testing

Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)

Who this might be right for
Cystitis AcuteAntibiotic Resistant InfectionMedication Adherence+2 more
Wuerzburg University Hospital 154
Testing effectiveness (Phase 2)Study completedNCT00105157
What this trial is testing

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 179
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableStudy completedNCT02605499
What this trial is testing

Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)

Who this might be right for
Healthcare Associated InfectionMultidrug Resistant Organisms
Johns Hopkins University 83
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Large-scale testing (Phase 3)Study completedNCT00621504
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 606
Not applicableStudy completedNCT03470233
What this trial is testing

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Korea Otsuka Pharmaceutical Co., Ltd. 149
Testing effectiveness (Phase 2)Study completedNCT02619994
What this trial is testing

Treatment Shortening of MDR-TB Using Existing and New Drugs

Who this might be right for
Tuberculosis, Multidrug-Resistant
Seoul National University Hospital 214
Not applicableStudy completedNCT02841501
What this trial is testing

Genetic Susceptibility Factors for Candidemia.

Who this might be right for
Invasive CandidiasisCandidemiaGenetic Predisposition to Disease
University Hospital, Lille 453
Not applicableWithdrawnNCT02640495
What this trial is testing

Artemisinin Resistance In Malaria Treated With IV Artesunate

Who this might be right for
Malaria
University of Oxford
Post-approval studies (Phase 4)Ended earlyNCT04040075
What this trial is testing

Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy

Who this might be right for
HIV-1-infection
Southampton Healthcare, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Looking for participantsNCT05835206
What this trial is testing

Further MT for Antibiotic-Resistant Bacterial Colonization

Who this might be right for
Intestinal Multi-drug Resistant Organism Colonization
Emory University 40
Not applicableUnknownNCT05300776
What this trial is testing

M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia

Who this might be right for
Pneumonia
Chinese PLA General Hospital 166
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Not applicableStudy completedNCT03357588
What this trial is testing

The Intensified Treatment Monitoring Strategy to Prevent Accumulation of Drug Resistance (ITREMA) Trial

Who this might be right for
HIV/AIDS
UMC Utrecht 501
Next Page